<rst>
<header>
	<relations>
			<rel name="purpose" type="rst"/>
			<rel name="background" type="rst"/>
			<rel name="elaboration" type="rst"/>
			<rel name="circumstance" type="rst"/>
			<rel name="cause" type="rst"/>
			<rel name="concession" type="rst"/>
			<rel name="antithesis" type="rst"/>
			<rel name="preparation" type="rst"/>
			<rel name="restatement" type="rst"/>
			<rel name="contrast" type="multinuc"/>
			<rel name="joint" type="multinuc"/>
			<rel name="sequence" type="multinuc"/>
			<rel name="same_unit" type="multinuc"/>
		</relations>
</header>
<body>
<segment id="1" parent="1001" relname="preparation">1. Introduction</segment>
<segment id="2" parent="1003" relname="span">In 2030 , in Western Europe and in the ten most populous nations of the world , the estimated number of individuals with Parkinson ’s disease</segment>
<segment id="3" parent="2" relname="restatement">( PD )</segment>
<segment id="4" parent="1002" relname="same_unit">will be over 8 million .</segment>
<segment id="5" parent="1005" relname="span">One of the main challenges</segment>
<segment id="6" parent="1006" relname="span">to be faced will be the development of technological and cost-effective solutions</segment>
<segment id="7" parent="6" relname="purpose">to improve the healthcare of these patients .</segment>
<segment id="8" parent="1008" relname="same_unit">Remote medical communications , for example in the form of telemedicine and decentralized care pathways ,</segment>
<segment id="9" parent="1008" relname="same_unit">will inevitably become part of the clinical management of such disease .</segment>
<segment id="10" parent="1004" relname="joint">Among the tougher hurdles to overcome ,</segment>
<segment id="11" parent="1011" relname="span">there is the accurate , low-cost and objective quantification of the typical motor symptoms ,</segment>
<segment id="12" parent="1012" relname="span">which is a key issue</segment>
<segment id="13" parent="12" relname="purpose">for obtaining a complete indication of the patient ’s state of impairment .</segment>
<segment id="14" parent="1016" relname="span">Since 1967 ,</segment>
<segment id="15" parent="1017" relname="span">when the motor effects of Levodopa</segment>
<segment id="16" parent="15" relname="restatement">( LD )</segment>
<segment id="17" parent="1015" relname="same_unit">on bradykinesia have been shown for the first time in a video ,</segment>
<segment id="18" parent="1014" relname="span">the way has been traced towards the quantification of movement disorders and their therapeutic response .</segment>
<segment id="19" parent="1020" relname="span">This pathway passes through semi-quantitative rating scales , such as the Hoehn and Yahr stage and unified Parkinson ’s disease rating scale</segment>
<segment id="20" parent="19" relname="elaboration">( UPDRS ) ,</segment>
<segment id="21" parent="1021" relname="span">which is still the gold standard scale</segment>
<segment id="22" parent="21" relname="purpose">for assessing symptoms in PD .</segment>
<segment id="23" parent="1023" relname="span">Evaluation through the UPDRS score is a subjective process</segment>
<segment id="24" parent="1024" relname="span">that comes after a global clinical judgment for the diagnosis</segment>
<segment id="25" parent="24" relname="elaboration">in which the experience of the specialist in movement disorders is crucial .</segment>
<segment id="26" parent="1026" relname="span">This process is , in fact , characterized by an intrinsic inter-rater variability</segment>
<segment id="27" parent="1027" relname="span">due to the different experience of the examiners ,</segment>
<segment id="28" parent="27" relname="elaboration">influencing the final judgment on the impairment severity .</segment>
<segment id="29" parent="1030" relname="concession">A percentage of incorrect diagnosis of 25 % has also been reported ,</segment>
<segment id="30" parent="1030" relname="span">especially</segment>
<segment id="31" parent="30" relname="circumstance">when symptoms such as essential tremor , vascular parkinsonism and atypical parkinsonian syndromes manifest .</segment>
<segment id="32" parent="1034" relname="span">Another difficulty</segment>
<segment id="33" parent="32" relname="purpose">to overcome ,</segment>
<segment id="34" parent="1034" relname="elaboration">shared by all clinical assessment scales ,</segment>
<segment id="35" parent="1032" relname="same_unit">is the mandatory presence of the specialist :</segment>
<segment id="36" parent="1035" relname="joint">this strongly influences the clinical management of the patient ,</segment>
<segment id="37" parent="1035" relname="joint">as all the therapeutic decisions are restricted at the time of the single medical examination .</segment>
<segment id="38" parent="1035" relname="joint">However , during the time interval between two consecutive examinations , the patient ’s motor status may change significantly , out of the examiner ’s sight .</segment>
<segment id="39" parent="1040" relname="span">The chance</segment>
<segment id="40" parent="39" relname="elaboration">of monitoring any change of the impairment in PD subjects over time ,</segment>
<segment id="41" parent="1041" relname="span">possibly daily and in a domestic environment ,</segment>
<segment id="42" parent="41" relname="elaboration">could have a strong impact on the clinical management of the patients and , consequently , on the long-term costs for the healthcare system .</segment>
<segment id="43" parent="1043" relname="span">In an attempt</segment>
<segment id="44" parent="1044" relname="joint">to address these challenges</segment>
<segment id="45" parent="1044" relname="joint">and quantify motor symptoms ,</segment>
<segment id="46" parent="1047" relname="span">motion analysis studies have played a growing role</segment>
<segment id="47" parent="1048" relname="span">in managing subjects with PD ,</segment>
<segment id="48" parent="47" relname="elaboration">exploring kinematic variables on gait ; tremor ; bradykinesia and rigidity .</segment>
<segment id="49" parent="1049" relname="contrast">Motion capture systems are the reference standard for motion analysis ,</segment>
<segment id="50" parent="1050" relname="span">but they are expensive and non-portable ,</segment>
<segment id="51" parent="1051" relname="span">so their use is limited to laboratory environments and scientific research</segment>
<segment id="52" parent="51" relname="antithesis">rather than to a routine clinical use .</segment>
<segment id="53" parent="1054" relname="circumstance">Therefore , in order to overcome these hurdles ,</segment>
<segment id="54" parent="1054" relname="span">it is urgent to find automatic and cost-effective solutions ,</segment>
<segment id="55" parent="1055" relname="span">capable of providing accurate and objective kinematic measures of motor performance and automatic scores</segment>
<segment id="56" parent="55" relname="elaboration">that are well correlated to the standard clinical ones .</segment>
<segment id="57" parent="1058" relname="span">Recently , various technological approaches have been proposed for the analysis of movement in PD ,</segment>
<segment id="58" parent="1059" relname="span">including wearable sensor networks</segment>
<segment id="59" parent="1060" relname="span">based on the use of inertial measurement units</segment>
<segment id="60" parent="59" relname="elaboration">( IMUs ) ,</segment>
<segment id="61" parent="1062" relname="span">smartphones and active vision systems</segment>
<segment id="62" parent="1063" relname="span">based on new low-cost RGB-Depth optical devices such as Microsoft Kinect®</segment>
<segment id="63" parent="62" relname="elaboration">( Microsoft Corporation , Redmond , WA , USA )</segment>
<segment id="64" parent="1064" relname="span">and Intel RealSense® SR300</segment>
<segment id="65" parent="64" relname="elaboration">( Intel Corporation , Santa Clara , CA , USA)[26 ] .</segment>
<segment id="66" parent="1066" relname="span">On the basis of these considerations , we propose the integration of two different sensor-based subsystems as a single solution for the objective , accurate and automated assessment of some standard tasks for the upper and lower limbs ,</segment>
<segment id="67" parent="1067" relname="span">as defined in the motor examination section</segment>
<segment id="68" parent="67" relname="elaboration">( Section 3 ) of UPDRS .</segment>
<segment id="69" parent="1070" relname="span">The first component is an active vision system</segment>
<segment id="70" parent="69" relname="elaboration">dedicated to the analysis of the motor tasks</segment>
<segment id="71" parent="1071" relname="joint">related to upper limbs ;</segment>
<segment id="72" parent="1072" relname="span">the second applies a body sensor network</segment>
<segment id="73" parent="72" relname="elaboration">( BSN ) approach with wireless wearable sensors for the analysis of the lower limb tasks .</segment>
<segment id="74" parent="1074" relname="span">The technical details of both and the validation of their accuracy as UPDRS automatic scoring systems</segment>
<segment id="75" parent="1075" relname="sequence">have been already presented in previous works</segment>
<segment id="76" parent="1075" relname="sequence">and will be briefly summarized in the Materials and Methods section .</segment>
<segment id="77" parent="1077" relname="span">A gesture-based human machine interface has been developed as part of the solution ,</segment>
<segment id="78" parent="77" relname="purpose">to simplify the interaction and the self-management of the system by people with impairment , in view of a possible use at home .</segment>
<segment id="79" parent="1078" relname="joint">The system is able to analyze and automatically score the patient movements during the performance of UPDRS tasks .</segment>
<segment id="80" parent="1080" relname="joint">In addition , it archives in the Cloud the kinematic data , the score and the video of each motor performance ,</segment>
<segment id="81" parent="1081" relname="joint">guaranteeing the remote supervision by clinicians</segment>
<segment id="82" parent="1081" relname="joint">and overcoming the mandatory presence of the specialist during the execution of the motor activities .</segment>
<segment id="83" parent="1082" relname="span">Finally , in view of a decentralized approach to the clinical management of the patient ,</segment>
<segment id="84" parent="1083" relname="span">the issue of acceptability and usability of the integrated system has been evaluated through a standard questionnaire .</segment>
<segment id="85" parent="1086" relname="span">The integrated system</segment>
<segment id="86" parent="85" relname="elaboration">here presented</segment>
<segment id="87" parent="1085" relname="same_unit">is aimed at a more comprehensive evaluation of the neuro-motor status of PD subjects by a decentralized approach ,</segment>
<segment id="88" parent="1084" relname="joint">and could represent a new example of an accurate , feasible and cost-effective strategy for the clinical management of PD .</segment>
<group id="1000" type="span" />
<group id="1001" type="span" parent="1000" relname="span"/>
<group id="1002" type="multinuc" parent="1004" relname="background"/>
<group id="1003" type="span" parent="1002" relname="same_unit"/>
<group id="1004" type="multinuc" parent="1001" relname="span"/>
<group id="1005" type="span" parent="1004" relname="joint"/>
<group id="1006" type="span" parent="5" relname="purpose"/>
<group id="1008" type="multinuc" parent="1004" relname="joint"/>
<group id="1011" type="span" parent="1004" relname="joint"/>
<group id="1012" type="span" parent="11" relname="elaboration"/>
<group id="1014" type="span" parent="1004" relname="joint"/>
<group id="1015" type="multinuc" parent="18" relname="circumstance"/>
<group id="1016" type="span" parent="1015" relname="same_unit"/>
<group id="1017" type="span" parent="14" relname="circumstance"/>
<group id="1019" type="span" parent="1004" relname="joint"/>
<group id="1020" type="span" parent="1019" relname="span"/>
<group id="1021" type="span" parent="1020" relname="elaboration"/>
<group id="1022" type="span" parent="1004" relname="joint"/>
<group id="1023" type="span" parent="1025" relname="preparation"/>
<group id="1024" type="span" parent="23" relname="elaboration"/>
<group id="1025" type="multinuc" parent="1022" relname="span"/>
<group id="1026" type="span" parent="1025" relname="joint"/>
<group id="1027" type="span" parent="26" relname="cause"/>
<group id="1029" type="span" parent="1025" relname="joint"/>
<group id="1030" type="span" parent="1029" relname="span"/>
<group id="1031" type="span" parent="1025" relname="joint"/>
<group id="1032" type="multinuc" parent="1035" relname="preparation"/>
<group id="1033" type="span" parent="1032" relname="same_unit"/>
<group id="1034" type="span" parent="1033" relname="span"/>
<group id="1035" type="multinuc" parent="1031" relname="span"/>
<group id="1039" type="multinuc" parent="1035" relname="joint"/>
<group id="1040" type="span" parent="1039" relname="same_unit"/>
<group id="1041" type="span" parent="1039" relname="same_unit"/>
<group id="1043" type="span" parent="1035" relname="joint"/>
<group id="1044" type="multinuc" parent="43" relname="purpose"/>
<group id="1045" type="span" parent="1035" relname="joint"/>
<group id="1046" type="span" parent="1045" relname="span"/>
<group id="1047" type="span" parent="1046" relname="span"/>
<group id="1048" type="span" parent="46" relname="elaboration"/>
<group id="1049" type="multinuc" parent="1047" relname="elaboration"/>
<group id="1050" type="span" parent="1049" relname="contrast"/>
<group id="1051" type="span" parent="50" relname="purpose"/>
<group id="1052" type="multinuc" parent="1046" relname="elaboration"/>
<group id="1053" type="span" parent="1052" relname="joint"/>
<group id="1054" type="span" parent="1053" relname="span"/>
<group id="1055" type="span" parent="54" relname="elaboration"/>
<group id="1056" type="multinuc" parent="1052" relname="joint"/>
<group id="1057" type="multinuc" parent="1056" relname="joint"/>
<group id="1058" type="span" parent="1057" relname="same_unit"/>
<group id="1059" type="span" parent="57" relname="elaboration"/>
<group id="1060" type="span" parent="58" relname="elaboration"/>
<group id="1061" type="multinuc" parent="1057" relname="same_unit"/>
<group id="1062" type="span" parent="1061" relname="same_unit"/>
<group id="1063" type="span" parent="61" relname="elaboration"/>
<group id="1064" type="span" parent="1061" relname="same_unit"/>
<group id="1065" type="multinuc" parent="1056" relname="joint"/>
<group id="1066" type="span" parent="1065" relname="joint"/>
<group id="1067" type="span" parent="66" relname="elaboration"/>
<group id="1068" type="multinuc" parent="1065" relname="joint"/>
<group id="1069" type="multinuc" parent="1068" relname="joint"/>
<group id="1070" type="span" parent="1069" relname="same_unit"/>
<group id="1071" type="multinuc" parent="1069" relname="same_unit"/>
<group id="1072" type="span" parent="1071" relname="joint"/>
<group id="1073" type="multinuc" parent="1068" relname="joint"/>
<group id="1074" type="span" parent="1073" relname="joint"/>
<group id="1075" type="multinuc" parent="74" relname="elaboration"/>
<group id="1076" type="multinuc" parent="1073" relname="joint"/>
<group id="1077" type="span" parent="1076" relname="joint"/>
<group id="1078" type="multinuc" parent="1076" relname="joint"/>
<group id="1079" type="multinuc" parent="1078" relname="joint"/>
<group id="1080" type="multinuc" parent="1079" relname="joint"/>
<group id="1081" type="multinuc" parent="1080" relname="joint"/>
<group id="1082" type="span" parent="1079" relname="joint"/>
<group id="1083" type="span" parent="83" relname="elaboration"/>
<group id="1084" type="multinuc" parent="84" relname="elaboration"/>
<group id="1085" type="multinuc" parent="1084" relname="joint"/>
<group id="1086" type="span" parent="1085" relname="same_unit"/>
	</body>
</rst>
